Trading a LENZ straddle lets you take a pure volatility position on LENZ Therapeutics Inc without committing to a direction. LENZ Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate LENZ straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on LENZ profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when LENZ Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the LENZ straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the LENZ straddle is the cleanest expression of that view. Our scanner prices every LENZ straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a LENZ straddle into a catalyst or short a LENZ straddle to harvest decay, the options straddle setups that matter are all in one place.
